Welcome to our dedicated page for Astrana Health news (Ticker: AMEH), a resource for investors and traders seeking the latest updates and insights on Astrana Health stock.
Astrana Health, Inc. (NASDAQ: AMEH) operates a physician-led healthcare model combining technology with value-based care delivery. This news hub provides investors and healthcare professionals with essential updates on the company's financial performance, strategic partnerships, and operational developments.
Access curated press releases and news analysis covering AMEH's value-based care initiatives, network expansions, and technology investments. Our repository includes updates on earnings reports, provider network growth, ESG progress, and regulatory developments affecting healthcare management operations.
Key content focuses on financial disclosures, care model innovations, and market expansion strategies across California, Texas, and other service areas. Stay informed about AMEH's physician empowerment programs, population health management advancements, and partnerships enhancing healthcare accessibility.
Bookmark this page for streamlined access to verified updates about Astrana Health's operational milestones. Check regularly for new developments in healthcare technology integration and value-based care delivery models.
Apollo Medical Holdings (NASDAQ: AMEH) reported its Q3 2021 financial results, revealing a diluted EPS of $0.74, a 64% increase year-over-year. Total revenue for Q3 reached $227.1 million, up 26%, while the company experienced a net loss of $5.4 million compared to a net income of $25.4 million in the same period last year. For the nine months ended September 30, total revenue grew to $578.8 million, a 13% increase, but net income fell to $68.6 million from $109.4 million. The company has raised its full-year 2021 guidance, reflecting organic growth and increased settlements.
Apollo Medical Holdings, Inc. has appointed Brandon Sim as Co-Chief Executive Officer (Co-CEO), effective November 2, 2021. This transition sees Kenneth Sim, M.D. stepping back to focus as Executive Chairman. Brandon Sim, previously the Chief Operating Officer, played a key role in ApolloMed's technology development and operations during the COVID-19 pandemic. He aims to further enhance the company's commitment to healthcare innovation and equity, utilizing its proprietary technology to support value-based care.
Apollo Medical Holdings, Inc. (NASDAQ: AMEH) announced an agreement to purchase the remaining 60% equity interest in Diagnostic Medical Group of Southern California (DMG) within three years. Currently owning 40% of DMG, this acquisition will consolidate DMG's financial statements with ApolloMed per U.S. GAAP. DMG, established in 1984, provides various outpatient imaging services across four locations in Southern California. The partnership aims to enhance operational efficiency and expand DMG's services to new markets.
Apollo Medical Holdings, Inc. (NASDAQ: AMEH) announced that its COO and CTO, Brandon Sim, along with CFO Eric Chin, will present at the Credit Suisse 30th Annual Healthcare Conference on November 9, 2021, at 9:10 a.m. PT. The virtual presentation will be accessible via the Company's website, with a recording available afterward. In addition, management will hold virtual one-on-one meetings during the event. ApolloMed focuses on providing technology-driven, value-based healthcare solutions, integrating risk-bearing services, and enhancing healthcare delivery.
Apollo Medical Holdings (NASDAQ: AMEH) will release its third quarter and nine-month financial results for 2021 on November 4, 2021, after market close. A conference call is scheduled for 2 p.m. PT / 5 p.m. ET on the same day to discuss these results. The call can be accessed via telephone or webcast, with a recording available post-event. ApolloMed focuses on value-based care, using technology solutions to enhance healthcare delivery. More details can be found on their investor relations page.
Clinigence Holdings has secured a $3 million strategic equity investment from Apollo Medical Holdings. This involves the issuance of 1,000,000 shares at $3.00 per share, along with warrants for an additional 500,000 shares at $3.50 each. The investment is positioned to enhance Clinigence's growth strategy and bolster its balance sheet as it aims for a NASDAQ uplisting. ApolloMed's COO, Brandon Sim, will join Clinigence's Board of Directors, highlighting the partnership's potential for operational synergies and future growth for both companies.
Clinigence Holdings, Inc. (OTC: CLNH) has completed a $3 million strategic equity investment from Apollo Medical Holdings, Inc. (NASDAQ: AMEH). Clinigence issued 1,000,000 shares at $3.00 each, accompanied by warrants for an additional 500,000 shares at $3.50 per share. ApolloMed's COO Brandon Sim will join Clinigence's Board. This investment aims to enhance Clinigence's growth strategy and strengthen its balance sheet for a potential NASDAQ uplisting. The partnership is expected to create operational synergies and bolster clinical outcomes in value-based care.
Apollo Medical Holdings, Inc. (NASDAQ: AMEH), a healthcare company focused on value-based care, is set to present at the 2021 Cantor Virtual Global Healthcare Conference on September 29, 2021, at 1:40 p.m. PT. The presentation will feature COO Brandon Sim and CFO Eric Chin. A live webcast will be available on the company's website, with a recording to follow. The company, headquartered in Alhambra, California, utilizes technology to enhance healthcare delivery through its integrated platform.
Apollo Medical Holdings, Inc. (NASDAQ: AMEH), a leader in physician-centric healthcare, announced the participation of COO Brandon Sim and CFO Eric Chin in two upcoming virtual investor events. The Colliers 2021 Institutional Investor Conference will take place on September 9, 2021, featuring one-on-one meetings with management. This will be followed by the Wells Fargo 2021 Virtual Healthcare Conference on September 10, 2021, where a corporate presentation is scheduled at 1 p.m. PT. Both events will allow for direct interaction with company leadership.
Apollo Medical Holdings has finalized a strategic alliance with CAIPA MSO, acquiring a 30% stake in the organization. This investment, which closed on August 27, 2021, supports ApolloMed's entry into the New York healthcare market. CAIPA MSO manages over 1,000 healthcare providers and serves approximately 500,000 patients, enhancing ApolloMed's technology-driven healthcare delivery platform. The collaboration aims to improve care quality and efficiency, benefiting patients and healthcare providers across the U.S.
FAQ
What is the market cap of Astrana Health (AMEH)?
